Original paper
Rivaroxaban in patients with mechanical heart valves: A pilot study
Abstract
Background Patients with mechanical heart valves are still not eligible for treatment with direct oral anticoagulants (DOAC). We aimed to conduct a proof-of-principle study investigating the anti-Xa inhibitor rivaroxaban as antithrombotic treatment in patients with recent mechanical aortic valve replacement. Materials and methods Low-risk patients scheduled for elective mechanical aortic valve replacement were treated with rivaroxaban 20 mg once...
Paper Details
Title
Rivaroxaban in patients with mechanical heart valves: A pilot study
Published Date
Feb 1, 2020
Journal
Volume
186
Pages
1 - 6
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History